BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11919561)

  • 21. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomere maintenance without telomerase.
    Lundblad V
    Oncogene; 2002 Jan; 21(4):522-31. PubMed ID: 11850777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple mechanisms of telomere maintenance exist in liposarcomas.
    Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
    Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere maintenance by telomerase and by recombination can coexist in human cells.
    Cerone MA; Londono-Vallejo JA; Bacchetti S
    Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
    Compton SA; Choi JH; Cesare AJ; Ozgür S; Griffith JD
    Cancer Res; 2007 Feb; 67(4):1513-9. PubMed ID: 17308089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
    Hills M; Lansdorp PM
    Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere configuration influences the choice of telomere maintenance pathways.
    Wen WY; Tsai HJ; Lin CC; Tseng SF; Wong CW; Teng SC
    Biochem Biophys Res Commun; 2006 May; 343(2):459-66. PubMed ID: 16546132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres].
    Yi BQ; Zhao B; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):67-71. PubMed ID: 18197499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability.
    Guiducci C; Cerone MA; Bacchetti S
    Oncogene; 2001 Feb; 20(6):714-25. PubMed ID: 11314005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process.
    Teng SC; Chang J; McCowan B; Zakian VA
    Mol Cell; 2000 Oct; 6(4):947-52. PubMed ID: 11090632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomere dynamics and genome stability in the human pancreatic tumor cell line MIAPaCa-2.
    Skrobot Vidacek N; Cukusić A; Ferenac Kis M; Ivanković M; Jevtov I; Mrsić S; Rubelj I
    Cytogenet Genome Res; 2007; 119(1-2):60-7. PubMed ID: 18160783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of telomeric instability.
    Baird DM
    Cytogenet Genome Res; 2008; 122(3-4):308-14. PubMed ID: 19188700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres.
    Akimcheva S; Zellinger B; Riha K
    Cytogenet Genome Res; 2008; 122(3-4):388-95. PubMed ID: 19188710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homologous recombination in Candida albicans: role of CaRad52p in DNA repair, integration of linear DNA fragments and telomere length.
    Ciudad T; Andaluz E; Steinberg-Neifach O; Lue NF; Gow NA; Calderone RA; Larriba G
    Mol Microbiol; 2004 Aug; 53(4):1177-94. PubMed ID: 15306020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.